Elevance Health Cash Flow Statement
NYSE: ELVHealth CareMedical SpecialitiesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Elevance Health free cash flow
In fiscal 2025, Elevance Health generated $4.29 billion of operating cash flow and spent $1.12 billion on capital expenditures. That left free cash flow of $3.17 billion, a free-cash-flow margin of 1.6% of revenue. Free cash flow was down 30.3% from the prior year's $4.55 billion.
Elevance Health returned $4.13 billion to shareholders: $1.53 billion in dividends and $2.60 billion in share repurchases, equal to 130% of free cash flow. Free cash flow covered dividend payments 2.1 times.
Summary generated from market data by MetaCap's automated system. Methodology
Elevance Health cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 5.66B | 5.97B | 5.99B | 5.89B | 6.15B | 4.57B | 4.81B | 3.75B | 3.84B | 2.47B |
| Net Income growth (YoY) | -5.19% | -0.33% | +1.75% | -4.24% | +34.49% | -4.89% | +28.19% | -2.42% | +55.59% | -3.52% |
| Depreciation & Amortization | 1.55B | 1.39B | 1.75B | 1.68B | 1.30B | 1.15B | 1.13B | 1.13B | 111.00M | 104.00M |
| Stock-Based Compensation | 276.00M | 191.00M | 289.00M | 264.00M | 255.00M | 283.00M | 294.00M | 226.00M | 170.00M | 165.00M |
| Change in Working Capital | -2.48B | 28.00M | -2.15B | -2.42B | -2.21B | -337.00M | -1.55B | -660.00M | 151.00M | -721.00M |
| Operating Cash Flow | 4.29B | 5.81B | 8.06B | 8.40B | 8.36B | 10.69B | 6.06B | 3.83B | 4.18B | 3.27B |
| Capital Expenditures | -1.12B | -1.26B | -1.30B | -1.15B | -1.09B | -1.02B | -1.08B | -1.21B | -791.00M | -584.00M |
| Investing Cash Flow | -1.34B | -5.17B | -5.57B | -4.56B | -9.64B | -7.32B | -2.79B | -1.26B | -5.08B | -514.00M |
| Dividends Paid | -1.53B | -1.51B | -1.40B | -1.23B | -1.10B | -954.00M | -818.00M | -776.00M | -705.00M | -684.00M |
| Share Repurchases | -2.60B | -2.90B | -2.68B | -2.32B | -1.90B | -2.70B | -1.70B | -1.69B | -2.00B | 0 |
| Debt Issued | 2.99B | 7.71B | 2.57B | 3.07B | 3.46B | 2.48B | 2.47B | 835.00M | 5.46B | 0 |
| Debt Repaid | -2.15B | -1.65B | -1.91B | -1.90B | -1.07B | -1.93B | -1.12B | -1.68B | -2.81B | 0 |
| Financing Cash Flow | -1.74B | 1.19B | -3.35B | -1.32B | 423.00M | -2.57B | -2.27B | -2.24B | 427.00M | -799.00M |
| Net Change in Cash | 1.20B | 1.83B | -861.00M | 2.51B | -861.00M | 804.00M | 1.00B | 325.00M | -466.00M | 1.96B |
| Free Cash Flow | 3.17B | 4.55B | 6.76B | 7.25B | 7.28B | 9.67B | 4.98B | 2.62B | 3.39B | 2.69B |
This table shows 10 annual periods of Elevance Health's cash flow statement, from FY 2025 back to FY 2016, across 14 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow ELV's reporting calendar. What is a cash flow statement?